Emma Morris

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

Emma Morris, Kirsty Thomson, Charles Craddock et al. · Blood · 2004 · 288 citations · Full text

Life Sciences, Immunology, Oncology +11

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

Karl S. Peggs, Ann Hunter, Rajesh Chopra et al. · The Lancet · 2005 · 277 citations

Life Sciences, Immunology, Oncology +3

Lentiviral gene therapy for X-linked chronic granulomatous disease

Donald B. Kohn, Claire Booth, Elizabeth M. Kang et al. · Nature Medicine · 2020 · 253 citations · Full text

Life Sciences, Immunology, Molecular Medicine +11

The evolution of cellular deficiency in GATA2 mutation

Rachel Dickinson, Paul Milne, Laura Jardine et al. · Blood · 2013 · 213 citations

Life Sciences, Genetics, Molecular Genetics +7

Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation

Alan Kennedy, Erin Waters, Behzad Rowshanravan et al. · Nature Immunology · 2022 · 212 citations · Full text

Life Sciences, Cell Biology, Immunology +17